Auriga downgrades athenahealth (Nasdaq: ATHN) from 'Buy' to 'Hold' and cuts the price target from $32 to $30.

The firm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE